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Background: Urgent care medicine is a rapidly growing health care sector where patients are
commonly treated for acute infectious diseaseserelated conditions. However, there are few
antimicrobial stewardship interventions described in these settings.
Objective: The objective of this study is to determine whether implementing outpatient
antimicrobial stewardship guidelines would improve antibiotic prescribing for acute upper
respiratory tract infections (ARTIs), skin and soft tissue infections (SSTI), and urinary tract
infections (UTI) at a single urgent care site.
Methods: This was a pre-post interventional study comparing antibiotic prescribing patterns for
ARTI, SSTI, and UTI at a single urgent care site in the preintervention group (November 2019 to
January 2020) with the postintervention group (November 2020 to January 2021) after implementation of outpatient stewardship guidelines. A second urgent care site that did not receive
any interventions served as a control. The outpatient stewardship guidelines were implemented
in October 2020 via didactic provider education and pocket guide distribution. The primary end
point was the rate of total guideline-concordant antibiotic prescribing. Secondary end points
included the rates of guideline concordance of each component of the prescription, including
antibiotic selection, duration, dose, therapy indication, and patient safety outcomes.
Results: The primary outcome of total guideline-concordant antibiotic prescribing signiﬁcantly
improved after implementation of outpatient antimicrobial stewardship guidelines at the study
site (50% vs. 70%, P < 0.001), which was also reﬂected when comparing postintervention study site
with postperiod control site (70% vs. 48%, P < 0.001). There was a statistically signiﬁcant
improvement in guideline-concordant duration of antibiotic therapy (43% vs. 61%, P ¼ 0.001),
driven by a reduction in antibiotic duration for UTI (7 [interquartile range (IQR) 5e7] vs. 5 [IQR 5e7]
days, P ¼ 0.007), which was also observed when comparing the postintervention study site with the
postperiod control site (61% vs. 48%, P ¼ 0.02). Patient safety outcomes were similar between
groups.
Conclusion: An antimicrobial stewardship intervention comprising institutional outpatient
guideline implementation and provider education signiﬁcantly improved total guidelineconcordant antibiotic prescribing by 20% for ARTI, UTI, and SSTI in an urgent care site.
© 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Background
Although hospital antimicrobial stewardship program (ASP)
interventions improve antibiotic prescribing in the inpatient
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settings, a recent national surveillance study revealed at least
30% of outpatient antibiotic prescriptions in the United States are
unnecessary, illustrating the need for ASPs to expand to outpatient clinical settings.1,2 In 2016, the Centers for Disease Control
and Prevention (CDC) published the Core Elements of Outpatient
Antibiotic Stewardship to provide guidance for clinicians practicing in outpatient care settings, such as primary care ofﬁces,
medical and surgical specialties, emergency departments, and
urgent cares.3 The 4 core elements are commitment, action for
policy and practice, tracking and reporting, and education and
expertise.3 In January 2020, The Joint Commission (TJC) instituted new requirements that echo the core elements developed
by the CDC for antimicrobial stewardship in the outpatient
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Key Points
Background:
 Urgent cares are a common setting for patients to
receive treatment for acute infectious diseases.
 There is a lack of outpatient stewardship interventions described in urgent care settings.

care system. This urgent care network operates more than 30
urgent care centers in a large metropolitan area. A second
urgent care site within the network with the same stafﬁng
model and similar patient volumes was selected to serve as a
control. Each urgent care location is staffed by 3 physicians and
3 advanced practice providers (APPs) and services more than
22,000 patient visits annually. Providers did not overlap between these 2 urgent care locations.
Study design

Findings:
 Implementing outpatient stewardship guidelines
significantly improved antibiotic prescribing by 20%
in the urgent care setting.
setting.4 Although both the CDC and TJC emphasize the
importance of collecting, analyzing, tracking, and reporting
stewardship data as a core stewardship strategy, hospital
ASPs may not have adequate resources to allow for timely
expansion to the outpatient setting.3,5 The new requirements
emphasize the identiﬁcation of antimicrobial stewardship
leaders, which are commonly antimicrobial stewardship
pharmacists or infectious diseases physicians with within
health care institutions. These leaders are not commonly
associated with outpatient sites, such as urgent care facilities,
creating a possible barrier for implementation of antimicrobial stewardship practices. Developing outpatient-speciﬁc
guidelines to establish antibiotic prescribing standards and
providing educational resources to clinicians about antibiotic
prescribing are 2 strategies that may require less time and
resources to implement.
Although there are several successful ASPs described in primary care practices, a paucity of literature exists exploring
antimicrobial stewardship initiatives in urgent care centers.6e11
Urgent care medicine is a rapidly growing health care sector
servicing high volumes of patients presenting with common
infections requiring antimicrobial therapy. A recent study reported that almost 40% of urgent care visits are linked with an
antibiotic prescription, compared with 7% with traditional
medical ofﬁce visits.10 In the outpatient setting, the 3 most
commonly encountered infectious disease states are acute respiratory tract infections (ARTI), including sinusitis, pharyngitis,
bronchitis, and other nonspeciﬁc respiratory tract infections;
urinary tract infections (UTIs); and skin and soft tissue infections
(SSTIs).11 Owing to the frequent use of antimicrobial agents in
each of the aforementioned disease states, they serve as quality
targets for establishing antimicrobial stewardship practices. The
purpose of this study was to evaluate whether a multimodal
stewardship approach with implementation of outpatient
institutional guidelines and provider education would improve
antibiotic prescribing for ARTI, UTI, and SSTI at a single urgent
care site.

This study was a pre-post interventional study design
evaluating the impact of implementing an outpatient antimicrobial stewardship guideline at a single urgent care site.
The preintervention period included patients treated from
November 1, 2019, to January 31, 2020. The postintervention
period included patients treated from November 1, 2020, to
January 31, 2021. A second urgent care clinic with similar
patient volume and number of providers was chosen as the
control site. The control urgent care location was evaluated
for the same antibiotic prescribing outcomes during the
same time periods as the study site, although they did not
receive the intervention. Given the pre-post study design,
each urgent care clinic location was intended to serve as its
own control. All adult patients at the age of at least 18 years
who were treated for ARTI (including sinusitis, pharyngitis,
bronchitis, or other nonspeciﬁc upper respiratory tract
infection), UTI, or SSTI were included. A list of patients
treated for ARTI, UTI, and SSTI was extracted from the
electronic medical record based on their ICD-10 diagnosis
code, antibiotic prescriptions issued during the study time
frames, and medications for symptomatic treatment (e.g.,
urinary analgesics, cough suppressants, antipyretics). This
list was randomized within each time period to account for
potential temporal confounding factors, such as seasonality,
(e.g., antibiotic prescribing may have improved in November
immediately after the implementation of guidelines but may
have waned over the following months), and then screened
for inclusion. Patients were excluded if any of the following
criteria were met: concurrent treatment with an antibiotic at
index visit, recurrent or chronic infection, conﬁrmed positive
rapid diagnostic test for inﬂuenza or severe acute respiratory
syndrome coronavirus 2 (coronavirus disease 2019 [COVID19]), known exposure to a person with COVID-19, complicated cystitis or pyelonephritis, treatment of suspected
polymicrobial SSTI (e.g., secondary to animal bite, diabetic
foot infection, or burn), pregnancy, or immunocompromised
patients. The group size between urgent care locations, time
periods, and infection types were planned to each contain
the same number of patients for equal size group comparisons. The randomized patient lists by disease state and time
period with the least number of patients were exhaustively
screened ﬁrst, and then the other randomized patient lists
were screened and included the same number of patients.

Methods

Outpatient antimicrobial stewardship guidelines

Study location

Before this study, institutional inpatient guidelines for the
treatment of UTI and SSTI were already published. For this
study, a new outpatient stewardship guideline was developed with a focus on acute sinusitis, acute pharyngitis, acute

This institutional review boardeapproved study was conducted at a single urgent care site afﬁliated with a large health
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bronchitis, other nonspeciﬁc upper respiratory tract infections, uncomplicated and complicated cystitis, and mild
SSTI. The guideline summarized the clinical signs and
symptoms, diagnostic criteria, common organisms, and
antibiotic prescribing recommendations for each disease
state. Information included in this outpatient guideline were
based on national clinical practice guidelines and recommendations, including the Infectious Diseases Society of
America and the American Academy of Family Physicians.12e16 This outpatient guideline was then reviewed
during a 1-hour didactic lecture presented to the study site
providers by 2 pharmacists and an infectious diseases
physician. The outpatient stewardship guideline was also
condensed into a pocket card resource and distributed to the
study site providers. All providers of the study site were
present for the didactic lecture reviewing the new outpatient
antimicrobial guideline. The control site did not receive any
antimicrobial stewardship interventions.
Study end points
The primary end point of this study was to compare the
rate of total guideline-concordant antibiotic therapy before
versus after the implementation of outpatient antimicrobial
stewardship guidelines. Total guideline concordance was
deﬁned as meeting all of the following criteria as outlined by
the outpatient stewardship guidelines: guideline-concordant
therapy indication, guideline-concordant drug selection,
guideline-concordant dosage, guideline-concordant frequency, and guideline-concordant duration. Each individual
component of the antibiotic prescription was evaluated as
secondary end points. Baseline patient demographic information, including the Charlson comorbidity index, antibiotic
allergies, and provider type, was collected. Patient safety
outcomes, such as adverse effects, infection-related revisits,
infection-related hospitalizations, and new Clostridioides
difﬁcile infection, were also evaluated.
Statistical analysis
A sample size calculation performed a priori estimated
that at least 712 patients per site would be needed to detect a
10% change in the primary end point using a 2-sided alpha of
0.05 and 80% power. The primary end point of total guidelineconcordant antibiotic regimens between the preintervention
and postintervention groups was compared using Pearson
chi-square test. Secondary end points collected as categorical
data were compared using Pearson chi-square test or the
Fisher exact test, as appropriate. For the secondary end points
of
guideline-concordant
drug
selection,
guidelineconcordant dosage, guideline-concordant frequency, and
guideline-concordant duration, the antibiotic prescriptions
that were not guideline concordant for therapy indication
(e.g., antibiotics prescribed for acute bronchitis) were
excluded from analysis. The baseline demographics of patients’ age between groups were compared using the t test.
The Charlson comorbidity index scores and durations of
antibiotic therapy in days were compared between groups
using the Mann-Whitney U test. Statistical analyses were
performed using SPSS software, version 26.0 (IBM Corp,
Armonk, NY).

Results
Baseline patient demographics
After screening 1398 patients for eligibility for matched
group size between urgent care sites, time periods, and
infection types, each urgent care site had a total of 520 patients
that met criteria for inclusion. Of the 520 patients, 260 patients
represented the preintervention period and 260 patients were
from the postintervention period. Each time period was
further divided into 150 patients with ARTI, 80 patients with
UTI, and 30 patients with SSTI (Figure 1). The most common
reason for exclusion was caused by a positive rapid diagnostic
test for COVID-19 or inﬂuenza or known exposure to person
with COVID-19. With the COVID-19 pandemic occurring during the postperiod of this study, there were overall fewer patient visits at both sites in the postperiod so ultimately this
study did not meet power. Baseline patient demographics
were overall similar within and between groups for both the
study site and control site, with the exception of an older patient population (47.9 [±17.4] vs. 44.2 [±16.9] years, P ¼ 0.02)
and more male patients (33% vs. 25%, P ¼ 0.04) in the preperiod control site than the preintervention study site. In
addition, more patients were treated by an APP in the postperiod at the control site than the preperiod (56% vs. 42%, P ¼
0.002) (Table 1).

Primary and secondary outcomes
The primary outcome of total guideline-concordant antibiotic prescribing signiﬁcantly improved after implementation of outpatient antimicrobial stewardship guidelines at the
study site (50% vs. 70%, P < 0.001), which was also reﬂected
when comparing the postintervention study site with the
postperiod control site (70% vs. 48%, P < 0.001) (Table 2). No
statistically signiﬁcant difference was found in guidelineconcordant frequency both within and between groups.
However, the preintervention study site compared with the
preperiod control site had signiﬁcantly higher rates of
guideline-concordant drug choice (81% vs. 71%, P ¼ 0.03) and
guideline-concordant drug dose (95% vs. 90%, P ¼ 0.01),
although no differences were found within each site by time
period.
Furthermore, a statistically signiﬁcant improvement was
observed for guideline-concordant antibiotic duration at the
study site (43% vs. 61%, P ¼ 0.001), which was also reﬂected
when comparing the postintervention study site with the
postperiod control site (61% vs. 48%, P ¼ 0.02). The overall
reduced antibiotic duration of therapy in the study site was
primarily seen in patients with UTI (preintervention 7
[interquartile range (IQR) 5e7] vs. postintervention 5 [IQR
5e7] days, P ¼ 0.007). The secondary outcome of guidelineconcordant therapy indication was not signiﬁcantly different
between the preintervention and postintervention groups
within the study site; however, in the control site, there was
a statistically signiﬁcant improvement in guidelineconcordant therapy indication when comparing the preperiod with postperiod groups (86% vs. 92%, P ¼ 0.02). The results of a subgroup analysis by infection type showed a
statistically signiﬁcant improvement in guideline-concordant
therapy indication for patients with ARTI within the study
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Figure 1. Distribution of patients by location, time period, and disease state. Abbreviations used: ARTI, acute respiratory tract infection; UTI, urinary tract infection;
SSTI, skin and soft tissue infection.

site (87% vs. 94%, P ¼ 0.03) and also within the control site
(77% vs. 87%, P ¼ 0.02). We also observed a signiﬁcantly
higher percentage of guideline-concordant therapy indication for UTI in our subgroup analysis when comparing the

postperiod control site with the postintervention study site
(100% vs. 90%, P ¼ 0.004).
Regarding patient safety outcomes, there was no difference
between groups at the study site (Table 3). Most patient safety

Table 1
Baseline patient demographics
Variable

Study site (N ¼ 520)
Preintervention
(n ¼ 260)

Mean age, y (± SD)
44.2 (± 16.9)
Male sex, n (%)
65 (25)
Advanced practice provider, n (%)
131 (50)
Beta-lactam allergy, n (%)
41 (16)
Sulfonamide allergy, n (%)
16 (6)
History of MRSA, n (%)
1 (4)
Recent surgical history, n (%)
2 (1)
Charlson Comorbidity Index, score (IQR)
0 (0e2)

Control site (N ¼ 520)

Postintervention
(n ¼ 260)

P value Preperiod
(n ¼ 260)

44.6
68
131
41
16
1
6
0

0.8
0.76
1.0
1.0
1.0
1.0
1.0
0.25

(± 17.1)
(26)
(50)
(16)
(6)
(4)
(2)
(0e2)

47.9
86
110
40
28
2
2
0

Postperiod
(n ¼ 260)

(± 17.4) 46.0 (± 18.9)
(33)
77 (30)
(42)
145 (56)
(15)
28 (11)
(11)
25 (10)
(1)
2 (1)
(1)
5 (2)
(0e2)
0 (0e2)

P value
P value Study pre vs. Study post vs.
control pre
control post
0.23
0.4
0.002
0.12
0.66
1.0
0.25
0.55

0.02
0.04
0.07
0.9
0.06
0.56
1.0
0.08

0.4
0.38
0.22
0.09
0.14
0.56
0.76
0.99

Abbreviations used: IQR, interquartile range; MRSA, methicillin-resistant Staphylococcus aureus.
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Table 2
Primary and secondary outcomes
Study site (N ¼ 520)

Outcome

Total antibiotic guideline concordance, n (%)
Guideline-concordant therapy indication, n (%)
ARTI only, n (%)a
UTI only, n (%)a
SSTI only, n (%)a
Guideline-concordant drug choice, n (%)b
Guideline-concordant dosage, n (%)b
Guideline-concordant frequency, n (%)b
Guideline-concordant duration, n (%)b
Duration for acute sinusitis, d (IQR)
Duration for acute pharyngitis, d (IQR)
Duration for UTI, d (IQR)
Duration for purulent SSTI, d (IQR)
Duration for nonpurulent SSTI, d (IQR)

Control site (N ¼ 520)

P value

Preintervention
(n ¼ 260)

Postintervention
(n ¼ 260)

P value

Preperiod
(n ¼ 260)

Postperiod
(n ¼ 260)

P value Study pre Study post
vs. control vs. control
post
pre

130
236
130
76
30
130
152
149
69
10
10
7
10
10

182
243
141
72
30
131
148
139
94
7
10
5
10
10

< 0.001
0.26
0.03
0.37
1.0
0.37
0.64
0.36
0.001
0.19
0.09
< 0.01
1.0
1.0

112
224
115
79
30
118
144
149
80
10
10
6
10
10

125
240
131
80
29
132
158
147
81
7
10
7
10
10

0.25
0.02
0.02
1.0
1.0
0.17
0.06
0.35
0.92
0.65
0.26
0.35
0.40
0.28

(50)
(91)
(87)
(95)
(100)
(81)
(95)
(93)
(43)
(7e10)
(5e10)
(5e7)
(7e10)
(7e10)

(70)
(94)
(94)
(90)
(100)
(85)
(96)
(90)
(61)
(7e10)
(10e10)
(5e7)
(7e10)
(7e10)

(43)
(86)
(77)
(99)
(100)
(71)
(90)
(90)
(48)
(7e10)
(5e10)
(5e7)
(7e10)
(10e10)

(48)
(92)
(87)
(100)
(97)
(78)
(93)
(87)
(48)
(7e10)
(10e10)
(5e7)
(7e10)
(7e10)

< 0.001
0.61
0.05
0.004
1.0
0.09
0.22
0.29
0.02
0.06
0.22
0.17
0.27
0.9

0.11
0.1
0.03
0.17
1.0
0.03
0.01
0.28
0.39
0.68
0.15
0.03
0.75
0.28

Abbreviations used: ARTI, acute respiratory tract infection; UTI, urinary tract infection; SSTI, skin and soft tissue infection; IQR, interquartile range.
a
Reported percentages based on number of patient cases for each indication (i.e., 150 patients with ARTI, 80 patients with UTI, 30 SSTI patients).
b
Patient cases where antibiotics were appropriately withheld (e.g., no antibiotic prescription for acute bronchitis) or inappropriately prescribed (e.g., antibiotic
prescribed for acute bronchitis) were excluded from analysis.

parameters were similar between groups at the control site,
with the exception of less frequent infection-related revisits
within 7 days in the postperiod (8.1% vs. 3.8%, P ¼ 0.042).
Discussion
This study demonstrates the notable impact of an outpatient antimicrobial stewardship intervention consisting of
institutional outpatient guideline implementation and provider education. Total antibiotic prescribing improved by 20%
at the intervention site, which was largely driven by a significant reduction in antibiotic duration of therapy in patients
with UTIs and an improvement in ARTI guideline-concordant
therapy indication. The improvement in the primary
outcome was not observed in the control site, although this
study did not meet power to detect a difference in the primary
outcome at a single site. Although didactic education alone is
not recommended in the inpatient setting as a sustainable
method to improve antibiotic prescribing practices owing to
the staff volume and frequent staff rotation, this study suggests that didactic education may be a worthwhile

intervention for urgent care centers that have a consistent core
of providers.5
A recent study by Laude et al.17 observed a signiﬁcant
reduction in antibiotic prescribing across 5 urgent care sites
after implementing several antimicrobial stewardship strategies, including provider education, development of institutional guidelines, and automation of antibiotic prescribing
data. The authors note that implementation of a robust
stewardship program was initially labor and resource intensive, but the sustainability of interventions was permissible
owing to automation of reporting processes. With the urgent
care network involved in this study including more than 30
urgent care sites, a strategic approach to implementing
automated or electronic stewardship initiatives is highly
critical.
Didactic education and the implementation of facilityspeciﬁc outpatient guidelines are both minimally time- and
labor-intensive stewardship interventions. Because there
were existing inpatient treatment guidelines for UTIs and
SSTIs for our health care system, minimal resources were
required to reformat the information into an outpatient

Table 3
Patient safety outcomes
Study site (N ¼ 520)

Outcome

Additional antibiotic prescribed within 72 h, n
(%)
Adverse drug event within 72 h, n (%)
Infection-related revisit within 7 d, n (%)
Infection-related revisit within 30 d, n (%)
Hospitalizations within 7 d, n (%)
Hospitalizations within 30 d, n (%)
Clostridioides difﬁcile infection within 30 d, n (%)

Control site (N ¼ 520)

P value

Preintervention Postintervention P value Preperiod Postperiod P value Study pre
(n ¼ 260)
(n ¼ 260)
(n ¼ 260) (n ¼ 260)
vs. control
pre

Study post
vs. control post

10 (4)

9 (4)

0.82

7 (3)

4 (2)

0.54

0.46

0.6

1 (0.4)
21 (8)
17 (7)
1 (0.4)
0 (0)
0 (0)

3 (1)
16 (6)
18 (7)
1 (0.4)
0 (0)
0 (0)

0.62
0.39
0.86
1.0
d
d

0 (0)
21 (8)
19 (7)
2 (1)
1 (0.4)
0 (0)

0 (0)
10 (4)
15 (6)
1 (0.4)
0 (0)
0 (0)

d
0.04
0.48
1.0
1.0
d

0.32
1.0
0.73
1.0
0.37
d

0.08
0.3
0.59
1.0
1.0
d
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guideline. The didactic educational materials were also
developed and presented by pharmacy residents, with the
oversight of infectious diseases specialists, as a part of their
residency training curriculum for providing in-service education to health professionals. ASPs with limited resources
may choose to focus on implementing similar practices
initially, while working to establish sustainable stewardship
interventions such as electronic order sets, automated
reporting, or prospective audit and feedback.3,5 Our study
identiﬁed that an area with a large opportunity for
improvement is the reduction in duration of therapy for UTI.
Focused education on this particular disease state may be a
strategy that ASPs can consider. The practical steps to
implementing antimicrobial stewardship interventions
should be tailored to the available resources and the unique
needs of each institution.
Interestingly, an improvement for guideline-concordant
therapy indication speciﬁcally for ARTIs was observed within
both the study site and control site and when comparing data
between sites. We hypothesize that this may be attributed to
the confounding factor of the COVID-19 pandemic. The presence of COVID-19 may have normalized acute respiratory
illness of viral etiology to both patients and providers. This
may have allowed for more frequent clinical scenarios where
antibiotics were appropriately withheld, given that there were
similar rates of increased concordance at both sites. The control site did not observe an improvement in antibiotic duration
for UTIs, suggesting that the improvement witnessed in the
study site may be caused by our educational intervention.
There was a statistically signiﬁcant difference in guidelineconcordant therapy indication for UTI in our subgroup analysis when comparing the postintervention study site with the
postperiod control site, which highlights the potential need to
focus on the treatment of asymptomatic bacteriuria during
educational sessions and other antimicrobial stewardship
interventions.
There are several limitations to be considered regarding
this study. First, patient chart review occurred retrospectively,
and thus, the results are limited by the accuracy and quality of
documentation in the electronic medical record. We hypothesize that the improvement in infection-related 7-day revisit
rate in the control site may be attributed to this limitation,
although we cannot be certaindgiven that the study site is
physically located next to its afﬁliated hospital and outpatient
clinics, there was the potential for more information to be
available regarding follow-up visits through the shared electronic medical record. In contrast, the control site is located
remotely and neighbors nonafﬁliated health care facilities that
may use different medical record systems, so information
regarding follow-up visits was likely limited and not available
for our analysis. Owing to the low overall number of infectionrelated revisits in both groups, it is difﬁcult to ascertain the
clinical signiﬁcance of these results. The retrospective nature
of this study also poses a limitation in providing an explanation for why more patients in the postperiod of the control site
were treated by APPs and whether this difference affected the
results of this study. However, the current urgent care network
policy requires APPs to staff most patient cases with the
physicians on site, so we believe that this difference does not
play a signiﬁcant role in our ﬁndings. Another limitation of this
study is that it does not assess whether the antimicrobial

stewardship strategies implemented are sustainable after the
initial 3-month period and an intervention ﬁdelity assessment
was not conducted. However, all providers were required to
attend the single educational session at the intervention site
and were encouraged to ask questions throughout the session.
Furthermore, the short follow-up duration of our study owing
to time constraints for study completion did not allow the
authors to address the long-term sustainability of the educational intervention and whether re-education or additional
interventions were necessary.
Nevertheless, this study has allowed our institution’s ASP
to begin identifying areas for improvement in outpatient
antibiotic prescribing, developing sustainable stewardship
interventions such as electronic order sets, and create dialogue
about antimicrobial stewardship across the health care continuum. As pharmacist presence continues to expand in
ambulatory care settings, our study highlights possible initial
steps to developing sustainable relationships with outpatient
care providers without the constant presence of pharmacy
care providers. Although didactic education may provide
additional beneﬁt when coupled with further interventions
such as electronic order sets and prospective audit and feedback, building rapport with providers is an important ﬁrst step
in establishing an open line of communication to improve
antimicrobial stewardship practices. Providers at our intervention site expressed a keen interest in maintaining consistent contact with our inpatient ASP through quarterly didactic
education and implementing order sets for common infectious
disease states after the completion of the study. Our study
adds to the growing body of literature investigating the impact
of various antimicrobial stewardship strategies applied in urgent care centers, which is an undoubtedly important target
for antibiotic stewardship and a possible area for future
pharmacist involvement in the outpatient setting.
Conclusion
An outpatient antimicrobial stewardship strategy
comprising provider education and institutional guideline
implementation demonstrated signiﬁcant improvement in
outpatient antibiotic prescribing for ARTI, UTI, and SSTI. Urgent care centers will continue to be an important target for
antimicrobial stewardship interventions and our study
highlights possible areas of focus, namely duration of therapy. For organizations or ASPs with limited resources for
outpatient stewardship, initiating the measurement of antimicrobial stewardship metrics, developing and implementing facility-speciﬁc guidelines, and providing didactic
education to practitioners are effective strategies to improve
antibiotic prescribing.
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